![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » FDA Clears Yale’s Saliva-Based COVID-19 Test for Emergency Use
FDA Clears Yale’s Saliva-Based COVID-19 Test for Emergency Use
![COVID_19 test tubes](https://www.fdanews.com/ext/resources/COVID-19_TEST_BLUE.gif?t=1585263965&width=430)
The Yale School of Public Health has received an Emergency Use Authorization from the FDA for a saliva-based COVID-19 laboratory test.
The test is cheaper and less invasive than nasopharyngeal swabbing but yields similar outcomes, the university said. It said it expects labs to charge about $10 per sample.
The saliva-based test has been validated with reagents and instruments from multiple vendors, Yale said, enabling testing to continue if some vendors encounter supply-chain issues.
Upcoming Events
-
21Oct